Literature DB >> 6683035

Hypocholesterolemia and hypocortisolemia in acute and terminal Babesia bovis infections.

G S Elissalde, G G Wagner, T M Craig, M H Elissalde, L Rowe.   

Abstract

Sera from Babesia bovis-infected cross-bred cows and purebred steers were evaluated throughout the course of acute Babesia bovis infection for cholesterol and cortisol concentrations. Cholesterol and cortisol values of surviving cattle became markedly reduced (less than 50% of normal values) during the acute phase of the disease, Days 10-15 postinoculation, and returned to essentially normal values by the end of the 35 day experimental period. The combined control group values were approximately 2.98 mM/l cholesterol and 0.085 mM/l cortisol throughout the experimental period. The results suggest that if normal synthesis of cholesterol by hepatocytes or other tissues is not maintained, then cholesterol-derived compounds such as cortisol may not be produced at levels adequate to protect against the effects of stress and cell damage during the disease process.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6683035     DOI: 10.1016/0304-4017(83)90083-3

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  4 in total

1.  Studies on some blood parameters of crossbred calves with experimental Theileria annulata infections.

Authors:  A Singh; J Singh; A S Grewal; R S Brar
Journal:  Vet Res Commun       Date:  2001-05       Impact factor: 2.459

2.  Endocrine dysfunction in chronic severe ehrlichiosis with or without babesiosis in dogs.

Authors:  A Kumar; J P Varshney; V P Varshney
Journal:  Vet Res Commun       Date:  2006-11       Impact factor: 2.459

3.  Hypolipidemia: a word of caution.

Authors:  Rr Elmehdawi
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

4.  Investigation of hematological and biochemical parameters in small ruminants naturally infected with Babesia ovis.

Authors:  Bijan Esmaeilnejad; Mousa Tavassoli; Siamak Asri-Rezaei
Journal:  Vet Res Forum       Date:  2012       Impact factor: 1.054

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.